{
    "clinical_study": {
        "@rank": "102600", 
        "arm_group": [
            {
                "arm_group_label": "Cognitively Healthy Subjects", 
                "arm_group_type": "Experimental", 
                "description": "Subjects will receive an IV injection, 370 megabecquerel (MBq) (10 millicurie [mCi]), single dose of florbetapir F 18 at baseline. Cross-sectional and longitudinal subjects will receive an IV injection, 370 MBq (10 mCi), single dose of 18F-AV-1451 at baseline. Longitudinal subjects only will receive an IV injection, 370 MBq (10 mCi) of 18F-AV-1451 at 9 and 18 months."
            }, 
            {
                "arm_group_label": "MCI Subjects", 
                "arm_group_type": "Experimental", 
                "description": "Subjects will receive an IV injection, 370 MBq (10 mCi), single dose of florbetapir F 18 at baseline. Subjects will receive an IV injection, 370 MBq (10 mCi), single dose of 18F-AV-1451 at baseline, 9 months and 18 months."
            }, 
            {
                "arm_group_label": "AD Subjects", 
                "arm_group_type": "Experimental", 
                "description": "Subjects will receive an IV injection, 370 MBq (10 mCi), single dose of florbetapir F 18 at baseline. Subjects will receive an IV injection, 370 MBq (10 mCi), single dose of 18F-AV-1451 at baseline, 9 months and 18 months."
            }
        ], 
        "brief_summary": {
            "textblock": "This is a cross-sectional and longitudinal study that will evaluate imaging characteristics\n      of 18F-AV-1451 in cognitively healthy volunteers, mild cognitive impairment (MCI) and\n      Alzheimer's disease (AD) subjects."
        }, 
        "brief_title": "Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects", 
        "completion_date": {
            "#text": "August 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Alzheimer's Disease", 
        "condition_browse": {
            "mesh_term": "Alzheimer Disease"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Cognitively Healthy Subjects\n\n          -  \u2265 20 to \u2264 40 years of age OR \u2265 50 years of age\n\n          -  Mini-mental state examination (MMSE) \u2265 29\n\n          -  No significant history of cognitive impairment\n\n        MCI Subjects\n\n          -  \u2265 50 years of age\n\n          -  MMSE \u2265 24\n\n          -  Have MCI consistent with National Institute on Aging-Alzheimer's Association (NIA-AA)\n             working group's diagnostic guidelines for AD\n\n          -  Have a study partner that can report on subject's activities of daily living\n\n        AD Subjects\n\n          -  \u2265 50 years of age\n\n          -  MMSE > 10\n\n          -  Have possible or probable AD based on the NIA-AA working group's diagnostic\n             guidelines for AD\n\n          -  Have a study partner that can report on subject's activities of daily living\n\n        Exclusion Criteria:\n\n          -  Current clinically significant psychiatric disease\n\n          -  Evidence of structural brain abnormalities\n\n          -  History of moderate or severe traumatic brain injury\n\n          -  Current clinically significant cardiovascular disease or ECG abnormalities, or\n             additional risk factors for Torsades de Pointes\n\n          -  Current clinically significant infectious disease, endocrine or metabolic disease,\n             pulmonary, renal or hepatic impairment, or cancer\n\n          -  History of alcohol or substance abuse or dependence\n\n          -  Females of childbearing potential who are not surgically sterile, not refraining from\n             sexual activity or not using reliable methods of contraception\n\n          -  Have received or participated in a trial with investigational medications in the past\n             30 days\n\n          -  Have had a non-study related radiopharmaceutical imaging or treatment procedure\n             within 7 days prior to the study imaging session."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "230", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 16, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02016560", 
            "org_study_id": "18F-AV-1451-A05"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Cognitively Healthy Subjects", 
                    "MCI Subjects", 
                    "AD Subjects"
                ], 
                "intervention_name": "florbetapir F 18", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Amyvid", 
                    "18F-AV-45"
                ]
            }, 
            {
                "arm_group_label": [
                    "Cognitively Healthy Subjects", 
                    "MCI Subjects", 
                    "AD Subjects"
                ], 
                "intervention_name": "18F-AV-1451", 
                "intervention_type": "Drug", 
                "other_name": "T807"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "April 22, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Scottsdale", 
                        "country": "United States", 
                        "state": "Arizona", 
                        "zip": "85258"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sun City", 
                        "country": "United States", 
                        "state": "Arizona", 
                        "zip": "85351"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Santa Monica", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90404"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Haven", 
                        "country": "United States", 
                        "state": "Connecticut", 
                        "zip": "06510"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Fort Myers", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33912"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Orlando", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32806"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St. Petersburg", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33709"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "West Palm Beach", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33407"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Quincy", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02169"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Las Vegas", 
                        "country": "United States", 
                        "state": "Nevada", 
                        "zip": "89147"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "3", 
        "official_title": "An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease", 
        "overall_contact": {
            "email": "clinicaloperations@avidrp.com", 
            "last_name": "Avid Clinical Operations", 
            "phone": "215-298-0700"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "August 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Compare standard uptake value ratio (SUVR) in subjects with AD to subjects with MCI and cognitively healthy older individuals.", 
                "measure": "Cross-sectional 18F-AV-1451 Imaging Results", 
                "safety_issue": "No", 
                "time_frame": "80-130 minutes post injection"
            }, 
            {
                "description": "Assess the rate of change of tau deposition as measured by 18F-AV-1451 uptake (SUVR) over time.", 
                "measure": "Change in tau deposition over time", 
                "safety_issue": "No", 
                "time_frame": "18 months"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02016560"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Describe the tau SUVR distribution across age groups among cognitively healthy subjects.", 
            "measure": "18F-AV-1451 imaging in healthy individuals", 
            "safety_issue": "No", 
            "time_frame": "80-130 minutes post-injection"
        }, 
        "source": "Avid Radiopharmaceuticals", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Avid Radiopharmaceuticals", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}